المؤلفون: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C. C., Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

المصدر: Lefort , M , Sharmin , S , Andersen , J B , Vukusic , S , Casey , R , Debouverie , M , Edan , G , Ciron , J , Ruet , A , De Sèze , J , Maillart , E , Zephir , H , Labauge , P , Defer , G , Lebrun-Frenay , C , Moreau , T , Berger , E , Clavelou , P , Pelletier , J , Stankoff , B , Gout , O , Thouvenot , E , Heinzlef , O , Al-Khedr , A , Bourre ....

مصطلحات موضوعية: Fingolimod Hydrochloride/therapeutic use, Humans, Multiple Sclerosis/drug therapy, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Natalizumab/therapeutic use, Treatment Outcome, Effectiveness, Censoring, Propensity score, Causal contrasts, Positivity assumption, Indication bias

وصف الملف: application/pdf

العلاقة: https://vbn.aau.dk/da/publications/e1d7ae7e-a89a-4601-8b51-4fdd028bde43Test

الإتاحة: https://doi.org/10.1186/s12874-022-01623-8Test
https://vbn.aau.dk/da/publications/e1d7ae7e-a89a-4601-8b51-4fdd028bde43Test
https://vbn.aau.dk/ws/files/473179728/Lefort_et_al._2022_._Impact_of_methodological_choices_in_comparative_effectiveness_studies_application_in_natalizumab_versus_fingolimod_comparison_among_patients_with_multiple_sclerosis.pdfTest
http://www.scopus.com/inward/record.url?scp=85130953245&partnerID=8YFLogxKTest

المؤلفون: Bridel, Claire, Leurs, Cyra E, van Lierop, Zoë Y G J, van Kempen, Zoé L E, Dekker, Iris, Twaalfhoven, Harry A M, Moraal, Bastiaan, Barkhof, Frederik, Uitdehaag, Bernard M J, Killestein, Joep, Teunissen, Charlotte E

المصدر: ISSN: 0028-3878 ; Neurology, vol. 97, no. 19 (2021) p. e1898-e1905.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616.8, Adolescent, Disease Progression, Humans, Immunologic Factors / therapeutic use, Intermediate Filaments, Multiple Sclerosis / drug therapy, Multiple Sclerosis, Relapsing-Remitting / diagnostic imaging, Relapsing-Remitting / drug therapy, Natalizumab / therapeutic use, Prospective Studies

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34504023; https://archive-ouverte.unige.ch/unige:167344Test; unige:167344

الإتاحة: https://doi.org/10.1212/WNL.0000000000012752Test
https://archive-ouverte.unige.ch/unige:167344Test

المؤلفون: Brown, J. William L., Coles, Alasdair, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Trojano, Maria, Lugaresi, Alessandra, Bergamaschi, Roberto, Grammond, Pierre, Alroughani, Raed, Hupperts, Raymond, McCombe, Pamela, Van Pesch, Vincent, Sola, Patrizia, Ferraro, Diana, Grand'Maison, Francois, Terzi, Murat, Lechner-Scott, Jeannette, Flechter, Schlomo, Slee, Mark, Shaygannejad, Vahid, Pucci, Eugenio, Granella, Franco, Jokubaitis, Vilija, Willis, Mark, Rice, Claire, Scolding, Neil, Wilkins, Alastair, Pearson, Owen R., Ziemssen, Tjalf, Hutchinson, Michael, Harding, Katharine, Jones, Joanne, McGuigan, Christopher, Butzkueven, Helmut, Kalincik, Tomas, Robertson, Neil

المصدر: Brown , J W L , Coles , A , Horakova , D , Havrdova , E , Izquierdo , G , Prat , A , Girard , M , Duquette , P , Trojano , M , Lugaresi , A , Bergamaschi , R , Grammond , P , Alroughani , R , Hupperts , R , McCombe , P , Van Pesch , V , Sola , P , Ferraro , D , Grand'Maison , F , Terzi , M , Lechner-Scott , J , Flechter , S , Slee , M , Shaygannejad , V , ....

مصطلحات موضوعية: Adult, Alemtuzumab/therapeutic use, Cohort Studies, Disease Progression, Female, Fingolimod Hydrochloride/therapeutic use, Glatiramer Acetate/therapeutic use, Humans, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Interferon-beta/therapeutic use, Male, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Natalizumab/therapeutic use, Time-to-Treatment

وصف الملف: application/pdf

العلاقة: https://research-information.bris.ac.uk/en/publications/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest

الإتاحة: https://doi.org/10.1001/jama.2018.20588Test
https://hdl.handle.net/1983/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest
https://research-information.bris.ac.uk/en/publications/a55f9cf8-31ba-4e10-a3b8-18c5de6fae5fTest
https://research-information.bris.ac.uk/ws/files/182040003/DMT_SPMS_conversion_resubmission_3_final_clean.pdfTest
http://www.scopus.com/inward/record.url?scp=85059962064&partnerID=8YFLogxKTest

المؤلفون: Ladeira, F, Braz, L, Salgado, P, Vaz, S, Leitão, L, Félix, C, Correia, AS, Martins da Silva, A, Salgado, V, Ferreira, F, Vale, J, Sá, MJ, Capela, C

مصطلحات موضوعية: HSAC NEU, Adult, Female, Male, Humans, Cohort Studies, Disease Progression, Follow-Up Studies, Immunologic Factors / adverse effects, Immunologic Factors / therapeutic use, Multiple Sclerosis, Relapsing-Remitting / diagnosis, Relapsing-Remitting / drug therapy, Relapsing-Remitting / epidemiology, Natalizumab / adverse effects, Natalizumab / therapeutic use, Retrospective Studies, Portugal / epidemiology, Young Adult, Withholding Treatment / trends

العلاقة: Clin Neurol Neurosurg. 2019 Sep;184:105390.; http://hdl.handle.net/10400.17/4226Test

الإتاحة: http://hdl.handle.net/10400.17/4226Test

المؤلفون: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C. C., Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

المساهمون: Centre de Recherches sur l'Action Politique en Europe (ARENES), Université de Rennes (UR)-Institut d'Études Politiques [IEP] - Rennes-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Centre National de la Recherche Scientifique (CNRS), Recherche sur les services et le management en santé (RSMS), Université de Rennes (UR)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], University of Melbourne, Copenhagen University Hospital, Hospices Civils de Lyon (HCL), Centre de recherche en neurosciences de Lyon - Lyon Neuroscience Research Center (CRNL), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Fondation Eugène Devic EDMUS, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), i-SEP (i-SEP), CIC Strasbourg (Centre d’Investigation Clinique Plurithématique (CIC - P) ), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nouvel Hôpital Civil de Strasbourg-Hôpital de Hautepierre [Strasbourg], CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Lille, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Service de Neurologie [CHU Caen], Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Tumorothèque de Caen Basse-Normandie (TCBN), Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Service de Neurologie [CHU Clermont-Ferrand], CHU Gabriel Montpied [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand-CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand, Hôpital de la Timone [CHU - APHM] (TIMONE), CHU Saint-Antoine [AP-HP], Fondation Ophtalmologique Adolphe de Rothschild [Paris], Service de Neurologie [CHU Nimes] (Pôle NIRR), Hôpital Universitaire Carémeau [Nîmes] (CHU Nîmes), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes)-Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Institut de Génomique Fonctionnelle (IGF), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), CHI Poissy-Saint-Germain, CHU Amiens-Picardie, CHU Rouen, Normandie Université (NU), Centre Hospitalier Universitaire [Grenoble] (CHU), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology (U1064 Inserm - CR2TI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Monash University [Melbourne], The Royal Melbourne Hospital, École des Hautes Études en Santé Publique [EHESP] (EHESP), Université de Rennes (UR), Département Méthodes quantitatives en santé publique (METIS), Collectif de recherche handicap, autonomie et société inclusive (CoRHASI), OFSEP was supported by a grant provided by the French State and handled by the 'Agence Nationale de la Recherche', within the framework of the 'Investments for the Future' program, under the reference ANR-10-COHO-002, by the Eugène Devic EDMUS Foundation against multiple sclerosis and by the ARSEP Foundation. ML has recieved travel grant from ARSEP foundation for this project. The Clinical Outcomes Research unit at the University of Melbourne received funding from NHMRC (grant number 1140766, 1129789, and 1157717) to support this study. The MSBase Foundation is a not-for-profit organization that receives support from Biogen, Novartis, Merck, Roche, Teva Pharmaeutical Industries and Sanofi Genzyme. The Danish Multiple Sclerosis Registry did not receive any funding to collaborate in this study., ANR-10-COHO-0002,OFSEP,Observatoire Français de la Sclérose en Plaques(2010), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut d'Études Politiques [IEP] - Rennes-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-École des Hautes Études en Santé Publique [EHESP] (EHESP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lyon-Université de Lyon-Université Jean Monnet [Saint-Étienne] (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), CHU Toulouse [Toulouse], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Hospitalier Universitaire de Nîmes (CHU Nîmes), Université de Rennes (UNIV-RENNES), Bramow, Stephan/0000-0001-9482-1771, Sellebjerg, Finn/0000-0002-1333-9623, Heinzlef, O., Camdessanche, J. P., Turkoglu, R., Boz, C., Shaygannejad, V, Moreau, T., Sellebjerg, F., Onofrj, M., De Seze, J., Wahab, A., VAN WIJMEERSCH, Bart, Mathiesen, H. K., Bramow, S., Andersen, J. B., Zephir, H., Ben Nasr, H., Ciron, J., Al-Khedr, A., Granella, F., Spitaleri, D., Lebrun-Frenay, C., Ferraro, D., Trojano, M., Labauge, P., Thouvenot, E., Skibina, O., Magyari, M., Patti, F., Maimone, D., Kalincik, T., Buzzard, K., Dimitri-Boulos, D., Alroughani, R., Maillart, E., Koch-Henriksen, N., Hankiewicz, K., Rasmussen, P., V, Jensen, M. B., Lechner-Scott, J., Csepany, T., Casez, O., Soerensen , P. S., Lugaresi, A., McCombe, P., Defer, G., Terzi, M., Christensen, C. C. Hilt, Girard, M., Ruet, A., Berger , E., Maurousset, A., Duquette, P., Horakova, D., Laplaud, D. A., Casey, R., Edan, G., Schreiber, K., I, Lefort, M., Cabre, P., Maubeuge, N., Grammond, P., Prevost, J., Havrdova, E. K., Gout, O., Prat, A., Sola, P., Slee, M., Sharmin , S., Leray, E., Ozakbas, S., Grand'Maison, F., Montcuquet, A., Nifle, C., Eichau, S., Butzkueven, H., Karabudak, R., Vukusic, S., Debouverie, M., Clavelou, P., Stankoff, B., Pottier, C., Yamout, B., Vucic, S., Van der Walt, A., Pelletier, J., Bourre, B., Izquierdo, G., Frederiksen, J. L., Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T, Leray, E

المصدر: Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand’Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8Test
BMC Medical Research Methodology
BMC Medical Research Methodology, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
BMC Medical Research Methodology, BioMed Central, 2022, 22 (1), pp.155. ⟨10.1186/s12874-022-01623-8⟩
Lefort, M, Sharmin, S, Andersen, J B, Vukusic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, De Sèze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, J P, Maurousset, A, Ben Nasr, H, Hankiewicz, K, Pottier, C, Maubeuge, N, Dimitri-Boulos, D, Nifle, C, Laplaud, D A, Horakova, D, Havrdova, E K, Alroughani, R, Izquierdo, G, Eichau, S, Ozakbas, S, Patti, F, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand'Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, J, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Maimone, D, Skibina, O, Buzzard, K, Van der Walt, A, Karabudak, R, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Koch-Henriksen, N, Sellebjerg, F, Soerensen, P S, Hilt Christensen, C C, Rasmussen, P V, Jensen, M B, Frederiksen, J L, Bramow, S, Mathiesen, H K, Schreiber, K I, Butzkueven, H, Magyari, M, Kalincik, T & Leray, E 2022, ' Impact of methodological choices in comparative effectiveness studies : application in natalizumab versus fingolimod comparison among patients with multiple sclerosis ', BMC Medical Research Methodology, vol. 22, no. 1, 155 . https://doi.org/10.1186/s12874-022-01623-8Test

مصطلحات موضوعية: MESH: Fingolimod Hydrochloride, Indication bias, Multiple Sclerosis, MESH: Multiple Sclerosis, Relapsing-Remitting, Propensity score, Epidemiology, Positivity assumption, [SDV]Life Sciences [q-bio], Health Informatics, Effectiveness, Multiple sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosi, Humans, Fingolimod Hydrochloride/therapeutic use, MESH: Treatment Outcome, Censoring, Natalizumab/therapeutic use, MESH: Humans, Fingolimod Hydrochloride, Natalizumab, Effectivene, Causal contrasts, MESH: Natalizumab, MESH: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting/drug therapy, Causal contrast, Treatment Outcome, Multiple Sclerosis/drug therapy, Indication bia, Human

وصف الملف: application/pdf; ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b76c9aa3b89340f07462e048e392906eTest
https://avesis.deu.edu.tr/publication/details/fef052b9-7e13-4a9f-b86e-a900c3dd0924/oaiTest

المؤلفون: Clottu, A.S., Mathias, A., Sailer, A.W., Schluep, M., Seebach, J.D., Du Pasquier, R., Pot, C.

المصدر: Cell reports, vol. 18, no. 1, pp. 213-224

مصطلحات موضوعية: Adult, CD11 Antigens/metabolism, CD4-Positive T-Lymphocytes/drug effects, CD4-Positive T-Lymphocytes/metabolism, Cell Movement/drug effects, Humans, Hydroxycholesterols/pharmacology, Immunologic Memory/drug effects, Multiple Sclerosis/immunology, Multiple Sclerosis/metabolism, Multiple Sclerosis/pathology, Natalizumab/pharmacology, Natalizumab/therapeutic use, Receptors, G-Protein-Coupled/metabolism, G protein-coupled receptor Epstein-Barr virus-induced gene 2 (EBI2), lymphocyte trafficking, multiple sclerosis, natalizumab, oxysterols

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28052250; info:eu-repo/semantics/altIdentifier/eissn/2211-1247; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_C112D80A95345; https://serval.unil.ch/notice/serval:BIB_C112D80A9534Test; https://serval.unil.ch/resource/serval:BIB_C112D80A9534.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C112D80A95345Test

الإتاحة: https://doi.org/10.1016/j.celrep.2016.12.006Test
https://serval.unil.ch/notice/serval:BIB_C112D80A9534Test
https://serval.unil.ch/resource/serval:BIB_C112D80A9534.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_C112D80A95345Test

المؤلفون: Disanto, G., Benkert, P., Lorscheider, J., Mueller, S., Vehoff, J., Zecca, C., Ramseier, S., Achtnichts, L., Findling, O., Nedeltchev, K., Radue, E.W., Sprenger, T., Stippich, C., Derfuss, T., Louvion, J.F., Kamm, C.P., Mattle, H.P., Lotter, C., Du Pasquier, R., Schluep, M., Pot, C., Lalive, P.H., Yaldizli, Ö., Gobbi, C., Kappos, L., Kuhle, J., SMSC Scientific, Board

المساهمون: SMSC Scientific, Board, Ramseier, S., Achtnichts, L., Findling, O., Saxer, J., Nedeltchev, K., Remonda, L., Boxheimer, L., Kuhle, J., Kappos, L., Yaldizli£££Özguer£££ Ö., Derfuss, T., Sprenger, T., Limberg, M., Scheerer, I., Orleth, A., Treppke, F., Beregi, E., Stippich, C., Reinhardt, J., Fellner, I., Würfel, J., Radue, EW., Thoeni, A., Palatini, A., Pauli-Magnus, C., Fabbro, T., Benkert, P., Roesler, A., Mechati, S., Louvion, JF., Kamm, C., Chan, A., Mattle, H., Salmen, A., Kaeser, M., Wagner, F., Verma, R., Lalive, P., Di Marco, M., Haller, S., Lovblad, KO., Du Pasquier, R., Schluep, M., Pot, C., Granziera, C., Hagmann, P., Maeder, P., Gobbi, C., Zecca, C., Disanto, G., Tschuor, S., Cianfoni, A., Müller, S., Vehoff, J., Weber, J., Lotter, C.

المصدر: Plos One, vol. 11, no. 3, pp. e0152347

مصطلحات موضوعية: Adult, Biomarkers/blood, Biomarkers/cerebrospinal fluid, Brain/radiography, Cohort Studies, Demography, Female, Fingolimod Hydrochloride/therapeutic use, Follow-Up Studies, Humans, Immunosuppressive Agents/therapeutic use, Magnetic Resonance Imaging, Male, Middle Aged, Multiple Sclerosis/diagnosis, Multiple Sclerosis/drug therapy, Natalizumab/therapeutic use, Prognosis, Prospective Studies, Recurrence, Switzerland

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27032105; info:eu-repo/semantics/altIdentifier/eissn/1932-6203; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_745A35B87D485; https://serval.unil.ch/notice/serval:BIB_745A35B87D48Test; urn:issn:1932-6203; https://serval.unil.ch/resource/serval:BIB_745A35B87D48.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_745A35B87D485Test

الإتاحة: https://doi.org/10.1371/journal.pone.0152347Test
https://serval.unil.ch/notice/serval:BIB_745A35B87D48Test
https://serval.unil.ch/resource/serval:BIB_745A35B87D48.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_745A35B87D485Test

المؤلفون: Schwob, Jean-Marc, Samer, Caroline Flora, Lalive d'Epinay, Patrice, Eperon, Gilles Alain

المصدر: ISSN: 1195-1982 ; Journal of Travel Medicine, vol. 28, no. 3 (2021) taaa235.

مصطلحات موضوعية: info:eu-repo/classification/ddc/613, info:eu-repo/classification/ddc/616, info:eu-repo/classification/ddc/616.8, info:eu-repo/classification/ddc/617, Antibodies, Monoclonal/adverse effects, Monoclonal/therapeutic use, Humans, Immunosuppressive Agents/adverse effects, Immunosuppressive Agents/therapeutic use, Natalizumab/adverse effects, Natalizumab/therapeutic use, Risk Assessment, Vaccines, Attenuated/adverse effects, Attenuated/therapeutic use, Multiple sclerosis, Measles, Yellow fever, Immunosuppressive/immunomodulating (ISIM) medications, Immunosuppression,immunization

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33367888; https://archive-ouverte.unige.ch/unige:152591Test; unige:152591

الإتاحة: https://doi.org/10.1093/jtm/taaa235Test
https://archive-ouverte.unige.ch/unige:152591Test

المؤلفون: Heindl, Steffanie, Ricci, Alessio, Denes, Adam, Edbauer, Dieter, Liesz, Arthur, Carofiglio, Olga, Zhou, Qihui, Arzberger, Thomas, Lenart, Nikolett, Franzmeier, Nicolai, Hortobagyi, Tibor, Nelson, Peter T, Stowe, Ann M

المصدر: Journal of experimental medicine 218(8), e20202411 (2021). doi:10.1084/jem.20202411

مصطلحات موضوعية: info:eu-repo/classification/ddc/610, Animals, Autopsy, Brain: immunology, Brain: pathology, Brain Ischemia: drug therapy, Brain Ischemia: immunology, Brain Ischemia: pathology, Cell Proliferation, Female, Humans, Immunotherapy, Integrin alpha4: immunology, Lymphocyte Count, Male, Mice, Inbred C57BL, Natalizumab: pharmacology, Natalizumab: therapeutic use, Neuronal Plasticity: drug effects, Recovery of Function: drug effects, Stroke: immunology, Stroke: physiopathology, Stroke: therapy, T-Lymphocytes: immunology

جغرافية الموضوع: DE

العلاقة: info:eu-repo/semantics/altIdentifier/issn/1540-9538; info:eu-repo/semantics/altIdentifier/issn/1540-9358; info:eu-repo/semantics/altIdentifier/issn/0022-1007; info:eu-repo/semantics/altIdentifier/pmid/pmid:34037669; https://pub.dzne.de/record/157717Test; https://pub.dzne.de/search?p=id:%22DZNE-2021-01174%22Test

الإتاحة: https://doi.org/10.1084/jem.20202411Test
https://pub.dzne.de/record/157717Test
https://pub.dzne.de/search?p=id:%22DZNE-2021-01174%22Test

المؤلفون: Jean-Marc Schwob, Patrice H. Lalive, Caroline Flora Samer, Gilles Eperon

المصدر: Journal of Travel Medicine, Vol. 28, No 3 (2021) P. taaa235

مصطلحات موضوعية: Drug, medicine.drug_class, medicine.medical_treatment, media_common.quotation_subject, Immunosuppressive Agents/adverse effects, 030231 tropical medicine, Vaccines, Attenuated/adverse effects, Vaccines, Attenuated/therapeutic use, Antibodies, Monoclonal/therapeutic use, Monoclonal antibody, Antibodies, Monoclonal/adverse effects, Vaccines, Attenuated, Risk Assessment, Multiple sclerosis, 03 medical and health sciences, 0302 clinical medicine, Natalizumab, Medicine, Humans, 030212 general & internal medicine, media_common, ddc:613, ddc:616, Natalizumab/therapeutic use, ddc:617, business.industry, Natalizumab/adverse effects, Antibodies, Monoclonal, Immunosuppression, General Medicine, medicine.disease, ddc:616.8, Immunization, Immunosuppressive/immunomodulating (ISIM) medications, Immunology, Benefit risk assessment, Immunosuppressive Agents/therapeutic use, Yellow fever, business, Risk assessment, Immunosuppressive Agents, medicine.drug, Measles, Immunosuppression,immunization

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::877070b2c123de0203afb40aba6bd5d8Test
https://pubmed.ncbi.nlm.nih.gov/33367888Test